US9861644 — Stabilized modified release vitamin D formulation and method of administering same
Formulation · Assigned to Opko Ireland Global Holdings Ltd · Expires 2034-03-14 · 8y remaining
What this patent protects
This patent protects a stabilized formulation for controlled release of vitamin D compounds, specifically 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3, combined with a cellulosic compound.
USPTO Abstract
A stabilized formulation for controlled release of a vitamin D compound is disclosed. The formulation comprises one or both of 25-hydroxyvitamin D 2 and 25-hydroxyvitamin D 3 and a cellulosic compound. The stabilized formulations exhibit a stable dissolution profile following exposure to storage conditions and demonstrate improved pharmacokinetic parameters compared to unstabilized formulations.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.